|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Elto Pharma, Inc.
| | | Phone: | (408) 737-2734 | Fax: | (408) 852-4427 | Year Established: | 2017 | Ticker: | AMBS | Exchange: | OTCPK | Main Contact: | Gerald E. Commissiong, Interim CEO | | Company Description | Elto Pharma, a subsidiary of Amarantus BioScience, is focused exclusively on the further development of Eltoprazine, Amarantus' mid-stage central nervous system (CNS) symptomatic treatment for Adult Attention Deficit and Hyperactivity Disorder (Adult ADHD), Alzheimer's Aggression and Parkinson's disease Levodopa-induced Dyskinesia (PD-LID). | |
|
|
|
|
|